Skip to main content

Herpes Genitalis

  • Chapter
  • First Online:
European Handbook of Dermatological Treatments
  • 43 Accesses

Abstract

Genital herpes is a chronic viral infection in the genital area caused by the herpes simplex virus type 1 or type 2 (HSV-1, HSV-2). It is one of the several reasons of the genital ulcer disease (GUD) with recurrent blisters and painful erosions in the same area of the skin. Most cases of recurrent genital herpes are caused by HSV-2. Atypical clinical lesions and unclear manifestations should be confirmed by laboratory diagnosis using the PCR as the gold standard method for the diagnosis and identification of HSV-1 or HSV-2. The appropriate treatment with nucleoside analogues is recommended for first episodes as well as for painful recurrent genital herpes and should start as soon as possible and with high dosages. It offers clinical benefit for symptomatic individuals, partners, and neonates and can reduce the number of herpetic recurrences and asymptomatic viral shedding.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 349.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 449.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Benedetti JK, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med. 1994;121:847–54.

    Article  CAS  PubMed  Google Scholar 

  • Brown ZA, Selke S, Zeh J, et al. Acquisition of herpes simplex virus during pregnancy. N Engl J Med. 1997;337:509–15.

    Article  CAS  PubMed  Google Scholar 

  • Bryson YJ, Dillon M, Bernstein DI, Radolf J, Zakowsi P, Garratty E. Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study. J Infect Dis. 1993;167:942–6.

    Article  CAS  PubMed  Google Scholar 

  • Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, Mugo N, Mujugira A, et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med. 2010;362:427–39.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Corey L, Wald A. Maternal and neonatal herpes simplex virus infections. N Engl J Med. 2009;361:1376–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Corey L, Wald A, Patel R, et al. Once daily Valaciclovir to reduce the risk of transmission of genital herpes. N Engl J Med. 2004;350(1):11–20.

    Article  CAS  PubMed  Google Scholar 

  • Cowan FM, Copas A, Johnson AM, Ashley R, Corey L, Mindel A. Herpes simplex virus type 1 infection: a sexually transmitted infection of adolescence? Sex Transm Infect. 2002;78:346–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Coyle PV, O’Neill HJ, Wyatt DE, McCaughey C, Quash S, McBride MQ. Emergence of herpes simplex type 1 as the main cause of recurrent genital ulcerative disease in women in Northern Ireland. J Clin Virol. 2003;27:22–9.

    Article  CAS  PubMed  Google Scholar 

  • Crumpacker CS, Schnipper LE, Marlowe ST, Kowalsky PN, Hershey BJ, Levin MJ. Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. N Engl J Med. 1982;306:343–6.

    Article  CAS  PubMed  Google Scholar 

  • Dillon SM, Cummings SM, Rajagopalan S, Mc Cormack WC. Prospective analysis of genital ulcer disease in Brooklyn, New York. Clin Infect Dis. 1997;24:945–50.

    Article  CAS  PubMed  Google Scholar 

  • Engel JP, Englund JA, Fietcher CV, et al. Treatment of resistant herpes simplex virus with continuous-infusion acyclovir. JAMA. 1990;236:1662–4.

    Article  Google Scholar 

  • Five KH, Crumpacker CS, Mertz GJ, Hill EL, Boone GS, the Acyclovir Study Group. Recurrence and resistance pattern of herpes simplex virus following cessation of ≥ 6 years of chronic suppression with acyclovir. J Infect Dis. 1994;169:1338–41.

    Article  Google Scholar 

  • Fleming D, McQuillan G, Johnson R, et al. Herpes simplex virus type 2 in the United States. 1976 to 1994. N Engl J Med. 1997;337:1105–11.

    Article  CAS  PubMed  Google Scholar 

  • Gupta R, Wald A, Krantz E, et al. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract. J Infect Dis. 2004;190:1374–81.

    Article  CAS  PubMed  Google Scholar 

  • Johnson LS, Nahmias AJ, Magder RE, et al. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med. 1989;321:7–12.

    Article  CAS  PubMed  Google Scholar 

  • Lafferty WE, Downey L, Celum C, Wals A. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis. 2000;181:1454–7.

    Article  CAS  PubMed  Google Scholar 

  • Loveless M, Harris W, Sacks S. Treatment of first episode genital herpes with famciclovir. In: Programms and abstracts of the 35th interscience conference on antimicrobial agents and chemotherapy; 1995. San Francisco, California; 1995.

    Google Scholar 

  • Mertz GJ. Epidemiology of genital herpes infections. Infect Dis Clin North Am. 1993;7:825–39.

    Article  CAS  PubMed  Google Scholar 

  • Mitchell PS, Espy MJ, Smith TF, Toal DR, Rys PN, Berbari EF, Osmon DR, Persing DH. Laboratory diagnosis of central nervous system infections with herpes simples virus by PCR performed with cerebrospinal fluid specimens. J Clin Microbiol. 1997;35:2873–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Patel R, Kennedy OJ, Clarke E, et al. European guidelines for the management of genital herpes. Int J STD AIDS. 2017;28(14):1366–79.

    Article  PubMed  Google Scholar 

  • Pue MA, Benet LZ. Pharmacokinetics of famciclovir in man. Antivir Chem Chemother. 1993;4:47–55.

    Article  CAS  Google Scholar 

  • Ratnam I, Chiu C, Kandala NB, Easterbrook PJ. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis. 2006;42:418–27.

    Article  CAS  PubMed  Google Scholar 

  • Reeves WC, Corey L, Adams HG, Vontver LA, Holmes KK. Risk of recurrence after first episodes of genital herpes. N Engl J Med. 1981;305:315–9.

    Article  CAS  PubMed  Google Scholar 

  • Sacks SL, Aoki FY, Diaz-Mitoma F, Sellors J, Shafran SD. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes: a randomized, double-blind multicenter trial. Canadian Famciclovir Study Group. JAMA. 1996;276:44–9.

    Article  CAS  PubMed  Google Scholar 

  • Safarin S, Crumpacker C, Chatis P, et al. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. N Engl J Med. 1991;325:551–5.

    Article  Google Scholar 

  • Schacker T, Zeh J, Hu H, Shaughnessy M, Corey L. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J Infect Dis. 2002;186:1718–25.

    Article  PubMed  Google Scholar 

  • Shukla D, Spear PG. Herpesviruses and heapransulfate: an intimate relationship in aid of viral entry. J Clin Invest. 2001;108:503–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tronstein E, Johnston C, Huang ML, Selke S, Magaret A, Warren T, Corey L, Wald A. Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA. 2011;305:1441–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wald A, Zeh J, Selke S, et al. Virologic characterisitcs of subclinical and symptomatic genital herpes infections. N Engl J Med. 1995;333:770–5.

    Article  CAS  PubMed  Google Scholar 

  • Wald A, Matson P, Ryncarz A, Corey L. Detection of herpes simplex virus DNA in semen of men with genital HSV-2 infection. 1999. Sex Transm Dis. 1999;26:1–3.

    Article  CAS  PubMed  Google Scholar 

  • Wald A, Corey L, Timmler B, Magaret A, Warren T, Tyring S, et al. Helicase –primase inhibitor pritelivir for HSV-2 infection. N Engl J Med. 2014;370:201–10.

    Article  CAS  PubMed  Google Scholar 

  • Wals A, Selke S, Warren T, et al. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding. Sex Transm Dis. 2006;33:529–33.

    Article  Google Scholar 

  • Whitley RJ, Prichard M. A novel potential therapy for HSV. N Engl J Med. 2014;370:273–4.

    Article  CAS  PubMed  Google Scholar 

  • Wildy P. Herpes history and classification. In: Kaplan AS, editor. The herpes viruses. New York: Academic; 1973. p. 1–25.

    Google Scholar 

  • Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-03):27–32.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Angelika Stary .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Stary, A. (2023). Herpes Genitalis. In: Katsambas, A.D., Lotti, T.M., Dessinioti, C., D'Erme, A.M. (eds) European Handbook of Dermatological Treatments. Springer, Cham. https://doi.org/10.1007/978-3-031-15130-9_37

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-15130-9_37

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-15129-3

  • Online ISBN: 978-3-031-15130-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics